Cargando…

Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia

BACKGROUND: Neuroinflammation is involved in the mechanisms of levodopa-induced dyskinesia (LID). The canonical NF-κB activation signaling pathway plays a critical role in the neuroinflammation development and BET protein-induced NF-κB-mediated neuroinflammation. The inhibition of the BET protein fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Ying, Han, Li, Rong, Lu, Yang, Shuyuan, Song, Lu, Wu, Na, Liu, Zhenguo, Gan, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253514/
https://www.ncbi.nlm.nih.gov/pubmed/35801173
http://dx.doi.org/10.3389/fnins.2022.896322
_version_ 1784740506302939136
author Wan, Ying
Han, Li
Rong, Lu
Yang, Shuyuan
Song, Lu
Wu, Na
Liu, Zhenguo
Gan, Jing
author_facet Wan, Ying
Han, Li
Rong, Lu
Yang, Shuyuan
Song, Lu
Wu, Na
Liu, Zhenguo
Gan, Jing
author_sort Wan, Ying
collection PubMed
description BACKGROUND: Neuroinflammation is involved in the mechanisms of levodopa-induced dyskinesia (LID). The canonical NF-κB activation signaling pathway plays a critical role in the neuroinflammation development and BET protein-induced NF-κB-mediated neuroinflammation. The inhibition of the BET protein function has been reported to alleviate LID; however, its association with the canonical NF-κB signaling pathway in the 6-OHDA-lesioned striatum of the LID rat model remains unknown. Accordingly, we identified the status of the canonical NF-κB signaling pathway in the 6-OHDA-lesioned striatum of the LID rat model and whether the anti-dyskinetic effect of the BET inhibitor JQ1 was associated with its suppression on NF-κB-mediated neuroinflammation. METHODS: 6-OHDA PD rat models were treated with either L-dopa plus JQ1 or L-dopa alone. L-dopa treatment was given for 2 weeks, and the JQ1 treatment was given for 3 weeks and was initiated a week prior to L-dopa treatment. As a control, the sham rats were treated with JQ1 or Veh for 3 weeks. The ALO AIM assessment and cylinder test were performed during the treatment. Glial activation markers, pro-inflammatory substances, and critical proteins in the canonical NF-κB signaling pathway were tested in the lesioned striatum after the final treatment. RESULTS: JQ1 effectively alleviated LID without influencing motor improvement. In the lesioned striatum, L-dopa triggered an overactivation of the canonical NF-κB signaling pathway, with an increase in the phospho-IKKα/β, phospho-IκBα, and NF-κB nuclear translocation and its phosphorylation at Ser 536 and Ser 276 sites (p < 0.01 vs. sham group). L-dopa induced an overexpression of the pro-inflammatory substances of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and inducible nitric oxide synthase (iNOS), and the glial activation markers CD68 and GFAP. All the molecular changes were greatly inhibited by JQ1. CONCLUSION: L-dopa triggered an overactivation of the canonical NF-κB signaling pathway, leading to an enhanced neuroinflammation response in the 6-OHDA-lesioned striatum of LID rat models. The inhibition of the BET protein function significantly suppressed the activation of the canonical NF-κB signaling pathway in the striatum, alleviating the neuroinflammation response and the severity of LID.
format Online
Article
Text
id pubmed-9253514
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92535142022-07-06 Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia Wan, Ying Han, Li Rong, Lu Yang, Shuyuan Song, Lu Wu, Na Liu, Zhenguo Gan, Jing Front Neurosci Neuroscience BACKGROUND: Neuroinflammation is involved in the mechanisms of levodopa-induced dyskinesia (LID). The canonical NF-κB activation signaling pathway plays a critical role in the neuroinflammation development and BET protein-induced NF-κB-mediated neuroinflammation. The inhibition of the BET protein function has been reported to alleviate LID; however, its association with the canonical NF-κB signaling pathway in the 6-OHDA-lesioned striatum of the LID rat model remains unknown. Accordingly, we identified the status of the canonical NF-κB signaling pathway in the 6-OHDA-lesioned striatum of the LID rat model and whether the anti-dyskinetic effect of the BET inhibitor JQ1 was associated with its suppression on NF-κB-mediated neuroinflammation. METHODS: 6-OHDA PD rat models were treated with either L-dopa plus JQ1 or L-dopa alone. L-dopa treatment was given for 2 weeks, and the JQ1 treatment was given for 3 weeks and was initiated a week prior to L-dopa treatment. As a control, the sham rats were treated with JQ1 or Veh for 3 weeks. The ALO AIM assessment and cylinder test were performed during the treatment. Glial activation markers, pro-inflammatory substances, and critical proteins in the canonical NF-κB signaling pathway were tested in the lesioned striatum after the final treatment. RESULTS: JQ1 effectively alleviated LID without influencing motor improvement. In the lesioned striatum, L-dopa triggered an overactivation of the canonical NF-κB signaling pathway, with an increase in the phospho-IKKα/β, phospho-IκBα, and NF-κB nuclear translocation and its phosphorylation at Ser 536 and Ser 276 sites (p < 0.01 vs. sham group). L-dopa induced an overexpression of the pro-inflammatory substances of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and inducible nitric oxide synthase (iNOS), and the glial activation markers CD68 and GFAP. All the molecular changes were greatly inhibited by JQ1. CONCLUSION: L-dopa triggered an overactivation of the canonical NF-κB signaling pathway, leading to an enhanced neuroinflammation response in the 6-OHDA-lesioned striatum of LID rat models. The inhibition of the BET protein function significantly suppressed the activation of the canonical NF-κB signaling pathway in the striatum, alleviating the neuroinflammation response and the severity of LID. Frontiers Media S.A. 2022-06-21 /pmc/articles/PMC9253514/ /pubmed/35801173 http://dx.doi.org/10.3389/fnins.2022.896322 Text en Copyright © 2022 Wan, Han, Rong, Yang, Song, Wu, Liu and Gan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Wan, Ying
Han, Li
Rong, Lu
Yang, Shuyuan
Song, Lu
Wu, Na
Liu, Zhenguo
Gan, Jing
Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia
title Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia
title_full Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia
title_fullStr Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia
title_full_unstemmed Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia
title_short Inhibition of BET Protein Function Suppressed the Overactivation of the Canonical NF-κB Signaling Pathway in 6-OHDA-Lesioned Rat Model of Levodopa-Induced Dyskinesia
title_sort inhibition of bet protein function suppressed the overactivation of the canonical nf-κb signaling pathway in 6-ohda-lesioned rat model of levodopa-induced dyskinesia
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253514/
https://www.ncbi.nlm.nih.gov/pubmed/35801173
http://dx.doi.org/10.3389/fnins.2022.896322
work_keys_str_mv AT wanying inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia
AT hanli inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia
AT ronglu inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia
AT yangshuyuan inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia
AT songlu inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia
AT wuna inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia
AT liuzhenguo inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia
AT ganjing inhibitionofbetproteinfunctionsuppressedtheoveractivationofthecanonicalnfkbsignalingpathwayin6ohdalesionedratmodeloflevodopainduceddyskinesia